Nevirapine

Back to search

Molecule Structure

Scientific Name

Nevirapine

Description of the Drug

Nevirapine is a non-nucleoside reverse transcriptase inhibitor used as part of a management regimen for HIV-1 virus infection.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00238

Brand Name(s)

Nevirapine, Viramune, Viramune xr

Company Owner(s)

Micro Labs Ltd, Cipla Ltd, Apotex Inc, Mylan Laboratories Ltd, Sandoz Inc, Macleods Pharmaceuticals Ltd, Boehringer Ingelheim Pharmaceuticals Inc, Alvogen Inc, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Human immunodeficiency virus type 1 reverse transcriptase SINGLE PROTEIN INHIBITOR CHEMBL247

Unichem Links

SureChEMBL SCHEMBL3318
PharmGKB PA450616
Human Metabolome Database HMDB0014383
DrugBank DB00238
PubChem: Thomson Pharma 14872507
PubChem 4463
Mcule MCULE-8608154492
NMRShiftDB 60032853
LINCS LSM-5336
Nikkaji J420.601K
PDBe NVP
BindingDB 1434
EPA CompTox Dashboard DTXSID7031797
DrugCentral 1904
Brenda 1896
ChemicalBook CB9743074
rxnorm NEVIRAPINE VIRAMUNE
PubChem: Drugs of the Future 12014582
KEGG Ligand C07263
ChEBI 63613
ZINC ZINC000000004778